Trial intelligence / Profile preview

Topical C-82 in Systemic Sclerosis

NCT02349009Phase 2Completed

Sponsor
Prism Pharmaceuticals
Start
Jun 2015
Primary completion
Jul 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of C-82 Topical Gel, Placebo in systemic sclerosis (SSc), sponsored by Prism Pharmaceuticals. Started Jun 2015; status: completed.

02

Drugs

C-82 Topical Gel, Placebo
03

Conditions

systemic sclerosis (SSc)

Beyond the preview

Go deeper on NCT02349009.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02349009.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call